fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

TIL Immunotherapy Drastically Increases the Number of Elite Cancer-Killing Lymphocytes in Your Body.

TIL Immunotherapy – Innovative Treatment to Fight Melanoma
Conventional cancer therapies are frequently ineffective against metastatic melanoma. TIL (tumor-infiltrating lymphocytes) immunotherapy is a highly progressive, promising treatment, with a high success rate.

TIL Immunotherapy – Innovative Treatment to Fight Melanoma

TILs, or tumor-infiltrating lymphocytes, are special immune system cells (T cells) that are naturally present inside some tumors. TIL therapy consists of collecting TILs from a tumor during a biopsy, or surgical resection, and growing them to very large numbers in a laboratory with interleukin-2 (IL-2), a protein that promotes rapid TIL growth. Once successfully grown to billions in number, the TILs are infused back into the patient, where they actively attack cancer cells while leaving healthy cells alone. After administering TIL immunotherapy, the size of the metastasis is often quickly reduced. This treatment is at the forefront of cancer therapies around the world, and it’s only offered by a few medical institutions. Sheba Medical Center performs TIL immunotherapy for metastatic melanoma for over 17 years.

til
til mob
Related
Sheba and Mayo Clinic merge Data-Sharing Network
News May 18.
Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…
Read More
Sheba Medical Center is working on enhancing patient safety with AI solutions.
News May 18.
Enhancing Patient Safety and Care with AI Solutions
With improving patient care a top priority, Sheba recognized technological innovation as an essential enabler of progress and transformation, with a particular emphasis on artificial…
Read More
IBD passport for patients with ulcerative colitis.
News May 17.
Meet the IBD Passport: A New Hope for Ulcerative Colitis and Crohn’s Disease Patients 
Ulcerative colitis (UC) and Crohn’s disease, the two most common forms of inflammatory bowel disease (IBD), can cause frustrating symptoms like diarrhea, abdominal pain, bloating,…
Read More